Thinly traded nano-cap stock, Ritter Pharmaceuticals $RTTR began its equity offering of 2,217,660 shares of common stock at $2.35. Underwriters will an option to purchase an additional 212,766 shares. The closing date is October 31. The proceeds from secondary offering will fund operations and other general corporate purposes. The stock closed at $2.68 on Wednesday.